Phase III trial comparing concurrent biochemotherapy with cisplatin, vinblastine, dacarbazine, interleukin-2, and interferon alfa-2b with cisplatin, vinblastine, and dacarbazine alone in patients with metastatic malignant melanoma (E3695): a trial coordinated by the Eastern Cooperative Oncology Group.

Atkins MB, Hsu J, Lee S, Cohen GI, Flaherty LE, Sosman JA, Sondak VK, Kirkwood JM, Eastern Cooperative Oncology Group
J Clin Oncol. 2008 26 (35): 5748-54

PMID: 19001327 · PMCID: PMC2645104 · DOI:10.1200/JCO.2008.17.5448

MeSH Terms (23)

Adult Aged Aged, 80 and over Antineoplastic Combined Chemotherapy Protocols Cyclophosphamide Dacarbazine Disease-Free Survival Female Humans Interferon-alpha Interferon alpha-2 Interleukin-2 Kaplan-Meier Estimate Male Melanoma Middle Aged Neoplasm Metastasis Recombinant Proteins Time Factors Treatment Outcome United States Vincristine Young Adult

Connections (1)

This publication is referenced by other Labnodes entities:

Links